A leading health organisation is urging the federal government to make the $300 RSV (respiratory syncytial virus) vaccine free for thousands of vulnerable Australians, as case numbers continue to rise across the country.
Nearly 120,000 RSV cases have been reported in Australia so far this year, with health experts warning of severe symptoms, especially among older adults. According to Professor Paul Griffin, Director of Infectious Diseases at Mater, the virus can lead to hospitalisation — and in some cases, even death.
Anne Fidler, who contracted the virus from her granddaughter, experienced symptoms including headaches, chest wheezing, and a runny nose. Her condition worsened rapidly due to a pre-existing lung condition, prompting her to seek specialist care. “Trying to get breath into my lungs… I thought this is not normal,” she said.
Currently, pregnant women in Australia are eligible for a free RSV vaccine that protects their newborns. If the mother hasn’t received the vaccine, the baby can be given an immunisation product after birth. However, for the general population — including vulnerable older adults — the vaccine costs around $300.
Professor Griffin emphasised that the vaccine is highly effective in reducing serious RSV outcomes, particularly for high-risk groups. Health advocates, including the Lung Foundation, are calling on the government to include RSV vaccination in the National Immunisation Program (NIP).
Three RSV vaccines have been approved in Australia for those aged 60 and over. The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended public funding for Pfizer’s vaccine for people aged 75+ and eligible Aboriginal and Torres Strait Islander adults, but it has yet to be listed due to concerns over cost-effectiveness. Pfizer is working with the Department of Health, while GlaxoSmithKline and Moderna have also submitted applications for funding consideration.
Until wider access is granted, vulnerable Australians are advised to take precautions. “Wearing a mask, or staying away from family members when they are unwell, are all small measures that can make a big difference,” said Lung Foundation CEO Mark Brooke.
